RGEN
Repligen Corporation
Latest News for RGEN
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Cardiff Oncology (CRDF) and Meiragt......
Guggenheim analyst reiterated a Hold rating on Repligen yesterday. The company’s shares closed yesterday at $126.43. In addition to Guggenheim, Rep......
In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Repligen, with a price target of $207.00. Arias covers the......
In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Repligen, with a price target of $207.00. Arias covers the......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Disc Medicine (IRON) and Cytokineti......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Disc Medicine (IRON) and Cytokineti......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on SOPHiA GENETICS (SOPH), CVRx (CVRX) and Repligen (RG......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN) and IQVIA Holdings (IQV) with bullis......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGEN | $115.19 | +0.1% | 799.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |